CD38 and Miyoshi myopathy: Isatuximab induced direct cytotoxicity without cross-linking in a dose-dependent manner in p53 mutated or deleted MM cell lines (RPMI8226, U266, JJN3) that correspond to unfavorable MM subgroups, which were transduced to overexpress CD38 [12].